Postpartum Intervention for Mothers With Opioid Use Disorders (R33)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorStony Brook University
About this trial
Having met the milestones of the R61, this R33 is a 2-site, 2-group, pre/post RCT of mothers with OUD (n=\~80/group). We will test whether the beneficial pre-post changes in OUD mothers randomized to vMP exceed those of mothers assigned to Enhanced Usual Care (EUC) and via changes in Maternal Brain Neurocircuits.
Eligibility criteria
Qualifiers
mothers with diagnosis of Opioid Use Disorder (OUD); and/or receiving medication assisted treatment (such as buprenorphine or methadone)
with a child aged 5 or less
able to read, hear and understand English adequately enough to provide informed consent
Disqualifiers
require immediate clinical care for suicidal/homicidal risk or psychosis;
For magnetic resonance imaging (MRI) of the brain, potential participants will be excluded if they: (1) have ferromagnetic metal in their heads (2) have severe claustrophobia that prevents participation in the neuroimaging (3) have serious neurological condition that could interfere with neuroimaging, including a brain tumor, multiple sclerosis or significant head trauma
Trial design
Treatments tested in this trial
- Mom Power
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Stony Brook University
Lead sponsor
University of Michigan
Collaborator
Source ClinicalTrials.gov